Core Insights - Conestoga Capital Advisors reported strong equity market performance in Q3 2025, with the Conestoga Micro-Cap Composite returning 11.7% net-of-fees, while the Russell Microcap Growth Index returned 19.9% [1] Company Overview: Mama's Creations, Inc. - Mama's Creations, Inc. (NASDAQ:MAMA) specializes in manufacturing and marketing fresh deli-prepared foods, including meatballs and protein-based entrees [3] - The stock experienced a one-month return of -4.25% but gained 35.99% over the last 52 weeks, closing at $10.54 per share with a market capitalization of $426.856 million on October 17, 2025 [2] Financial Performance - In Q2 2026, Mama's Creations, Inc. reported a revenue increase of 24%, rising to $35.2 million from $28.4 million in the same quarter the previous year [4] - Strong demand for ready-to-eat products and expanded distribution with national grocers contributed to revenue growth [3] Market Position and Investor Sentiment - Mama's Creations, Inc. was held by 9 hedge fund portfolios at the end of Q2 2026, an increase from 7 in the previous quarter, indicating growing interest among institutional investors [4] - The company benefits from product innovation, brand recognition, and margin expansion due to improved scale and operating efficiency, which has positively influenced investor sentiment [3]

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets continued their momentum that began in early April, reaching new all-time highs in the third quarter. In the quarter, the Conestoga Small Cap Composite returned -1.4% net-of-fees, underperforming the Russell 2000 Growth Index’s impressive 12.2% gain. Most of the Index's gains come from low-quality stock leadership, where unprofitable, high-beta ...

Bruker Corporation (NASDAQ:BRKR) ranks among the best medical device stocks to invest in. Bruker Corporation (NASDAQ:BRKR) reported on October 3 that it had received new orders for advanced Nuclear Magnetic Resonance (NMR) instruments from three major US research organizations. The orders, valued at nearly $10 million, were from the New York Structural Biology Center (NYSBC), the University of Delaware, and Northwestern University. NYSBC has placed an order for the first Multifield NMR Relaxometry System ...

Core Insights - Lyft, Inc. has experienced a significant rally of over 50% this year, marking a notable recovery after years of stagnant trading [1] - Jim Cramer expressed optimism about Lyft's potential for further growth, suggesting that the stock may have more room to run [1] Company Performance - Lyft operates a platform that connects drivers and riders for on-demand transportation [1] - The stock recently saw a substantial increase, prompting discussions about its future performance [1] Investment Strategy - Cramer advised caution for investors looking to buy into Lyft after its recent surge, recommending to wait for a potential pullback before entering [1] - He suggested that investors who have seen significant gains might consider taking some profits while allowing the remaining investment to ride [1] Comparative Analysis - While acknowledging Lyft's potential, the article suggests that certain AI stocks may offer greater upside potential with less downside risk [1]

Graphic Packaging Holding Company (NYSE:GPK) is one of the oversold mid-cap stocks to buy according to hedge funds. On October 10, 2025, the company announced that longtime Chief Financial Officer Stephen Scherger will resign from his role effective November 7. Scherger, who has served as CFO since 2015, is set to join packaging rival Amcor as Executive Vice President and Chief Financial Officer starting November 10. Graphic Packaging’s CFO Heads to Rival Amcor, Interim Named Copyright: bialasiewicz / 1 ...

Abercrombie & Fitch Co. (NYSE:ANF) is one of the most oversold mid-cap stocks to buy according to hedge funds. On October 7, 2025, the company announced it will open a new distribution center in Columbus, Ohio, in partnership with Bleckmann, a European supply chain specialist. The facility is expected to be operational by summer 2026 and will serve as a key fulfillment hub for North American operations. According to the company, the move is aimed at boosting shipping speed, reducing logistics costs, and s ...

Chubb Limited (NYSE:CB) is included among the 15 Dividend Stocks that Have Raised Payouts for 20+ Years. Citizens Praises Chubb’s (CB) Global Franchise, Reiterates Market Outperform Rating Photo by Dan Dennis on Unsplash On October 14, Citiz‌ens ha⁠s reaffirme​d its Market Outperform ra⁠ting on Chubb Limited (NYSE:CB) a⁠nd set a pric‍e ta‌rget of $325.​ The firm maintained its optimistic view of the insurer, pointing to Chubb’s strong earnings per shar‌e growt‍h as a major reason for its continued confi ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best healthcare stocks with the highest upside. In a report released on October 14, Cantor Fitzgerald analyst Olivia Brayer reiterated a Buy rating for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). However, the analyst slashed the firm’s price target on the stock from $90 to $80. BioMarin Pharmaceutical Inc. (BMRN): Among Small-Cap Healthcare Stocks Hedge Funds is Buying J.P. Morgan analyst Jessica Fye also maintained a Buy rating on BioMarin Pharmac ...

Core Insights - Payoneer Global Inc. (NASDAQ:PAYO) is recognized as one of the best fintech stocks to buy according to analysts, with a reaffirmed Buy rating and a price target of $10 by Needham [1][2] - Recent discussions with Payoneer's leadership highlighted that US tariff increases on China are not as detrimental to the company as initially anticipated, and the company has identified strategies to increase its take-rates over time [2][3] Company Overview - Payoneer Global Inc. operates a cross-border payments platform, facilitating fund management across multiple currencies for businesses, freelancers, and online sellers [3] - The company's current valuation is considered inexpensive, with an enterprise value to EBITDA ratio of approximately 6.5x based on fiscal year 2026 estimates [3] Growth Potential - Stablecoins are identified as a potential driver for future growth, with new products and collaborations expected to enhance Payoneer's market share in a growing market [2]

Group 1 - Keurig Dr Pepper Inc. (NASDAQ: KDP) is considered one of the best high volume stocks to buy according to Wall Street analysts [1] - BofA lowered its price target on Keurig Dr Pepper to $33 from $41 while maintaining a Buy rating [1] - TD Cowen also reduced its price target on the company to $28 from $36 with a Hold rating, while maintaining its Q3 and 2025 EPS estimates [2] Group 2 - Keurig Dr Pepper operates through three segments: US Refreshment Beverages, US Coffee, and International [3]